Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Next-generation Sequencing
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 16, 2026

Annotation of Plant Gene Function via Combined Genomics, Metabolomics and Informatics
Published on: June 17, 2012
Joaquim V Marques1, Kye-Won Kim, Choonseok Lee
1Institute of Biological Chemistry, Washington State University, Pullman, Washington 99164-6340, USA.
Researchers identified two key enzymes, CYP719A23 and CYP719A24, in Podophyllum species. These enzymes convert (-)-matairesinol to (-)-pluviatolide, advancing our understanding of podophyllotoxin biosynthesis for cancer drugs.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: